C11orf94

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, C11orf94 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated C11orf94 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher C11orf94 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C11orf94 expression acts as an unfavorable survival marker.

COAD are the cancer types where C11orf94 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
COADOSMedianAll0.1810.806.00212view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

C11orf94–COAD (OS)

Kaplan–Meier survival curve for C11orf94 mutant vs wild-type samples in COAD.

Open the COAD breakdown →

Exploration